Internal Med Medical News about Pertussis vaccination; adults

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

AAFP Launches Awareness Campaign for Pertussis Vaccination. CDC Estimates 600,000 U.S. Cases Occur Each Year
American Family Physician, 08/27/09

Mitchell D – Only 2% of American adults received the tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, or Tdap, from 2005 through 2007.

To address this problem, the AAFP has launched a new initiative, Vaccination Matters: Help Protect Families From Whooping Cough. The first phase of the initiative, which is supported by funding from vaccine manufacturer GlaxoSmithKline, is designed to remind Academy members of the role they play in protecting families from the disease. The Vaccination Matters Web page features a multimedia presentation – hosted by Epperly – on select results of an Academy survey of members about their knowledge of and practices related to pertussis and pertussis immunization. Also included are patient information tear sheets, a fact sheet that summarizes results of the survey, and related articles from American Family Physician and Family Practice Management.
Sanofi pasteur's Tdap vaccine, Adacel, was approved by the FDA in June 2005 as a single booster dose in adolescents and adults ages 11–64. GlaxoSmithKline's version of the vaccine, Boostrix, received FDA approval the previous month for use in patients who are 10–18 years of age, an indication that subsequently was expanded to also include individuals ages 19–64 years.
ACIP recommended that adults who are 19–64 years of age receive a single booster dose of Tdap to replace tetanus and diphtheria toxoids vaccine, or Td, if patients received their last dose of Td 10 or more years earlier and have not previously received Tdap.
Adults most commonly receive tetanus boosters at urgent care or emergency facilities, which often provide Td, rather than Tdap, vaccine.
The AAFP's pertussis survey indicates that more than 80 percent of members think the disease is hard to diagnose in adults. That's all the more reason for us to be aware of the importance of vaccination so we can prevent this common illness.

<< Previous
Patient-Reported Dyspnea in COPD Reliability and Association With...

Next >>
Differences in Pulmonary Function Based on Height Prediction...